Barr Laboratories clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., Dec 23, 2008 · source ↗
The registry lists 1 studies whose lead sponsor is Barr Laboratories. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 26, 2013.
- 1study on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Barr Laboratories became part of Teva Pharmaceutical Industries, Ltd.
- 1
- First submitted after Barr Laboratories became part of Teva Pharmaceutical Industries, Ltd.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Barr Laboratories’ studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- Cyproterone1 in phase 30 open · 1
- Cyproterone Acetate1 in phase 30 open · 1
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed1100%
Registry sponsor names on this page
- Barr Laboratories1 study
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Teva Pharmaceutical Industries, Ltd. studies →
- Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate CancerCompletedNCT00005623Phase 3
Sponsor listed in the registry: Barr Laboratories · First submitted before Barr Laboratories became part of Teva Pharmaceutical Industries, Ltd.